We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00602862
First Posted: January 28, 2008
Last Update Posted: December 2, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Dutch Cancer Society
Information provided by (Responsible Party):
Radboud University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):